Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMRUBICIN for Thymoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where AMRUBICIN was used for Thymoma.

Most Reported Side Effects for AMRUBICIN

Side Effect Reports % Deaths Hosp.
Disease recurrence 30 19.1% 2 0
Neutropenia 22 14.0% 4 3
Drug ineffective 21 13.4% 12 2
Interstitial lung disease 17 10.8% 2 3
Febrile neutropenia 16 10.2% 5 2
Leukopenia 15 9.6% 4 2
Anaemia 14 8.9% 1 3
Acute myeloid leukaemia 13 8.3% 5 4
Disease progression 12 7.6% 5 1
Thrombocytopenia 12 7.6% 2 2
Small cell lung cancer 10 6.4% 2 0
Decreased appetite 8 5.1% 1 1
Off label use 8 5.1% 4 2
Diarrhoea 7 4.5% 1 0
Death 6 3.8% 6 0

Other Indications for AMRUBICIN

Small cell lung cancer (46) Small cell lung cancer recurrent (26) Small cell lung cancer extensive stage (17) Product used for unknown indication (11) Lung neoplasm malignant (8) Neuroendocrine carcinoma (8)

Other Drugs Used for Thymoma

DOXORUBICIN (94) CISPLATIN (93) CYCLOPHOSPHAMIDE (92) CARBOPLATIN (50) PACLITAXEL (47) ETOPOSIDE (34) PEMBROLIZUMAB (30) METHYLPREDNISOLONE (23) RITUXIMAB (23) NIVOLUMAB (21)

Related Pages

AMRUBICIN Full Profile All Thymoma Drugs AMRUBICIN Demographics AMRUBICIN Timeline